Syngenta Receives Approval for New Corn Technologies in Brazil

BASEL, Switzerland, Nov. 13 /PRNewswire-FirstCall/ --

• MIR162 corn and Bt11xGA21 stacked corn receive approvals
• Brazilian growers to gain increased competitiveness and productivity
• Further strengthens Syngenta portfolio in Brazilian market
  

Syngenta announced today that its genetically modified corn traits MIR162 and Bt11xGA21 are now fully approved for cultivation in Brazil. This follows the approval by the National Biosafety Committee and the thirty day clearance period. The approval of these advanced technologies will offer Brazilian growers increased productivity, higher grain quality and reduced production costs.

"These approvals reinforce Syngenta's leading position in technology and innovation, strengthen our portfolio of solutions and will enable Brazilian growers to increase their efficiency and global competitiveness," said Davor Pisk, Chief Operating Officer Seeds.

The efficacy and broad spectrum of MIR162 make it the most advanced technology available today to control the fall army worm, the main insect threat to corn in Brazil. The stacked corn trait Bt11xGA21 offers higher value and convenience for growers through combined insect resistance and herbicide tolerance.

Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com or www.growmorefromless.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.

    Syngenta International AG

    Media Office
    CH-4002 Basel
    Switzerland
    Tel:   +41 61 323 23 23
    Fax:   +41 61 323 24 24

    www.syngenta.com

    Media contact:

    Medard Schoenmaeckers
    Switzerland   +41 61 323 2323

    Analyst/Investor contacts:

    Jennifer Gough
    Switzerland   +41 61 323 5059
    USA           +1 202 737 6521

    John Hudson
    Switzerland   +41 61 323 6793
    USA           +1 202 737 6520

SOURCE Syngenta